QT
KRYS icon

Quantbot Technologies’s Krystal Biotech KRYS Stock Holding History

Quantbot Technologies’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.4K Buy
133
+47
+55% +$12.5K ﹤0.01% 1452
2025
Q4 		$21.2K Buy
+86
New +$18.1K ﹤0.01% 1565
2024
Q2 		– Sell
-137
Closed -$24.4K – 1694
2024
Q1 		$24.4K Buy
+137
New +$19K ﹤0.01% 1397
2021
Q4 		– Sell
-100
Closed -$5K – 1718
2021
Q3 		$5K Sell
100
-100
-50% -$5.92K ﹤0.01% 1410
2021
Q2 		$13K Buy
+200
New +$14K ﹤0.01% 1278

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's KRYS Position: Q1 2026 in Review

Quantbot Technologies increased its Krystal Biotech (KRYS) stake by 55% in Q1 2026, buying an estimated $12.5K and bringing the position to 133 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1452.

Quantbot Technologies first reported a position in KRYS in Q2 2021 and has held it in 5 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Quantbot Technologies held 133 shares of Krystal Biotech worth $34.4K as of Q1 2026.
  • Quantbot Technologies bought 47 Krystal Biotech shares in Q1 2026, an estimated $12.5K.
  • Krystal Biotech made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1452 holding.
  • Quantbot Technologies first reported a position in Krystal Biotech in Q2 2021 and has held it in 5 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.